Inomagen Therapeutics Revenue

Biotechnology Research • United States • 1-10 Employees

Inomagen Therapeutics revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding

Key Contact at Inomagen Therapeutics

Robin Drassler

Vice President of Business Development

Company overview

Headquarters	United States
Phone number	+13128058701
Website	inomagen.com
NAICS	541714
Employees	1-10
Socials

Inomagen Therapeutics Email Formats

Inomagen Therapeutics uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@inomagen.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@inomagen.com	100%

About Inomagen Therapeutics

Atrial fibrillation is the most common sustained heart rhythm disorder and a growing epidemic in an aging population. Unfortunately, current therapies have proven ineffective for many patients as they do not address the underlying mechanisms of the disease. At Inomagen, we are exclusively focused on discovering and developing transformative gene therapies to markedly improve the treatment of atrial fibrillation. Our scientific advancements have been the result of significant non-dilutive grant funding. The company has an exclusive license agreement with Northwestern University for a robust IP estate and has assembled a highly experienced team to bring our therapies to market.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Vice President

Funding Data

Inomagen Therapeutics has never raised funding before.

Inomagen Therapeutics Tech Stack

Discover the technologies and tools that power Inomagen Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Adobe Fonts

Font scripts

Modernizr

JavaScript libraries

Lodash

JavaScript libraries

reCAPTCHA

Security

Squarespace Commerce

Ecommerce

HubSpot Analytics

Analytics

Stimulus

JavaScript frameworks

HSTS

Security

Open Graph

Miscellaneous

core-js

JavaScript libraries

HubSpot

Marketing automation

Cart Functionality

Ecommerce

Frequently asked questions

Inomagen Therapeutics is located in US.

You can reach Inomagen Therapeutics at +13128058701.

Inomagen Therapeutics generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

Inomagen Therapeutics has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Inomagen Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Inomagen Therapeutics

Robin Drassler

Vice President of Business Development

4.8

40,000 users